Evox Therapeutics Limited

From potential use as gene therapy delivery vehicles to anti-inflammatory therapies and cancer drugs, there has been excitement around exosomes since these stem cell components were first observed in

“I’m optimistic when it comes to both the integration and the impact of transformative technologies across the life sciences industry,” said Jessica Federer , Bayer ’s former chief digital officer a

Since biotech valuations on public markets peaked in September 2021, the sector has had to contend with reduced financing availability and harsher conditions for deal-making. In December 2023, Scrip

Coming off the back of a challenging 2021 and 2022, many industry analysts cautiously forecast a bigger 2023, more deals, mergers and IPOs. While this has not happened, bar a few delicious morsels suc